MorphoSys AG
Antagonists of IL-17C for the treatment and/or prevention of atopic dermatitis
Last updated:
Abstract:
The present invention provides antagonists of IL-17C for use in the treatment and/or prevention of atopic dermatitis and related conditions.
Status:
Grant
Type:
Utility
Filling date:
5 Oct 2016
Issue date:
31 Mar 2020